SOUTH SAN FRANCISCO, Calif., Feb. 6, 2012 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that Peter Langecker, MD, PhD, President and Chief Executive Officer, will present a corporate overview and business update at the BIO CEO & Investor Conference 2012 on February 13, 2012 at 1:30 pm ET at the Waldorf-Astoria Hotel in New York City.